AR074821A1 - Proceso para preparar entecavir e intermediario para dicho proceso - Google Patents
Proceso para preparar entecavir e intermediario para dicho procesoInfo
- Publication number
- AR074821A1 AR074821A1 ARP090105004A ARP090105004A AR074821A1 AR 074821 A1 AR074821 A1 AR 074821A1 AR P090105004 A ARP090105004 A AR P090105004A AR P090105004 A ARP090105004 A AR P090105004A AR 074821 A1 AR074821 A1 AR 074821A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- protecting group
- hydroxy protecting
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
Reivindicación 1: Un método para preparar entecavir de la fórmula (1), caracterizado porque comprende los pasos de: (a) realizar olefinación de un compuesto alfa-hidroxi cetona de la fórmula (2) para obtener un compuesto exometileno de la fórmula (3); (b) llevar a cabo una reacción de Mitsunobu del compuesto exometileno de la fórmula (3) con un derivado de purina para obtener un compuesto nucleósido de la fórmula (4); (c) extraer los grupos protectores del compuesto nucleósido de la fórmula (4) para obtener un compuesto de la fórmula (5); y (d) hidrolizar el compuesto de la fórmula (5), en donde, R1 y R2 son cada uno, independientemente, H o un grupo protector hidroxi, o R1 y R2 se fusionan de manera conjunta para formar un grupo protector hidroxi cíclico, R3 se selecciona del grupo que consiste de H, alquilsililo, y alilsililo; y X se selecciona del grupo que consiste de cloro, yodo, y benciloxi. Reivindicación 12: Un compuesto cetona caracterizado porque es de fórmula (6) en donde R1 y R2 son cada uno, independientemente, H o un grupo protector hidroxi, o R1 y R2 se fusionan de manera conjunta para formar un grupo protector hidroxi cíclico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080134756A KR101150254B1 (ko) | 2008-12-26 | 2008-12-26 | 신규 중간체 및 이를 활용한 엔테카비르 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR074821A1 true AR074821A1 (es) | 2011-02-16 |
Family
ID=42288324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090105004A AR074821A1 (es) | 2008-12-26 | 2009-12-21 | Proceso para preparar entecavir e intermediario para dicho proceso |
Country Status (13)
Country | Link |
---|---|
US (1) | US8569490B2 (es) |
EP (1) | EP2382217B1 (es) |
JP (1) | JP5425933B2 (es) |
KR (1) | KR101150254B1 (es) |
CN (1) | CN102264739B (es) |
AR (1) | AR074821A1 (es) |
CA (1) | CA2747777C (es) |
HK (1) | HK1163083A1 (es) |
MY (1) | MY158838A (es) |
SA (1) | SA109310017B1 (es) |
SG (1) | SG171963A1 (es) |
TW (1) | TWI383983B (es) |
WO (1) | WO2010074534A2 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8569491B2 (en) * | 2009-10-12 | 2013-10-29 | Hanmi Science Co., Ltd | Method for preparing entecavir and intermediate used therein |
US8481728B2 (en) | 2010-02-16 | 2013-07-09 | Scinopharm Taiwan, Ltd. | Process for preparing entecavir and its intermediates |
CA2705953C (en) * | 2010-05-31 | 2018-05-01 | Alphora Research Inc. | Carbanucleoside synthesis and intermediate compounds useful therein |
CN102336754B (zh) * | 2010-07-15 | 2017-04-12 | 浙江奥翔药业股份有限公司 | 恩替卡韦的合成方法及其中间体化合物 |
EP2474548A1 (en) * | 2010-12-23 | 2012-07-11 | Esteve Química, S.A. | Preparation process of an antiviral drug and intermediates thereof |
EP2597096A1 (en) | 2011-11-24 | 2013-05-29 | Esteve Química, S.A. | Process for preparing entecavir and intermediates thereof |
US9169256B2 (en) | 2013-03-13 | 2015-10-27 | Elitechgroup B.V. | Artificial nucleic acids |
CA2913189C (en) * | 2013-06-25 | 2020-08-25 | The Walter And Eliza Hall Institute Of Medical Research | Method of treating intracellular infection |
WO2015051903A1 (en) * | 2013-10-08 | 2015-04-16 | Pharmathen S.A. | A novel process for the preparation of chiral cyclopentanone intermediates |
WO2015051900A1 (en) | 2013-10-08 | 2015-04-16 | Pharmathen S.A. | Process for the preparation of entecavir through novel intermediates |
CN103675185B (zh) * | 2013-12-10 | 2015-10-07 | 上海景峰制药股份有限公司 | 一种用高效液相色谱法测定恩替卡韦片中全反式异构体的方法 |
KR101647061B1 (ko) | 2014-04-02 | 2016-08-10 | 서강대학교산학협력단 | 무인자율주행 차량의 주행경로 생성방법 및 장치 |
CN105037363B (zh) * | 2015-07-13 | 2016-08-24 | 山东罗欣药业集团股份有限公司 | 一种恩替卡韦化合物的新合成方法 |
CN106554365B (zh) * | 2016-11-12 | 2019-01-08 | 嘉兴敏实机械有限公司 | 一种恩替卡韦中间体的制备工艺及其应用 |
CN109232637B (zh) * | 2018-10-29 | 2020-11-24 | 常州博海威医药科技股份有限公司 | 一种恩替卡韦中间体的制备方法 |
KR20210102364A (ko) * | 2018-12-12 | 2021-08-19 | 얀센 바이오파마, 인코퍼레이트. | 항바이러스제로서의 사이클로펜틸 뉴클레오시드 유사체 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5340816A (en) | 1990-10-18 | 1994-08-23 | E. R. Squibb & Sons, Inc. | Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines |
US5206244A (en) | 1990-10-18 | 1993-04-27 | E. R. Squibb & Sons, Inc. | Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines |
WO1998009964A1 (en) | 1996-09-03 | 1998-03-12 | Bristol-Myers Squibb Company | IMPROVED PROCESS FOR PREPARING THE ANTIVIRAL AGENT [1S-(1α, 3α, 4β)]-2-AMINO-1,9-DIHYDRO-9-[4-HYDROXY-3-(HYDROXYMETHYL)-2-METHYLENECYCLOPENTYL]-6H-PURIN-6-ONE |
PL212790B1 (pl) | 2002-12-11 | 2012-11-30 | Bristol Myers Squibb Co | Sposób wytwarzania entekawiru, produkty posrednie, sposób wytwarzania produktu posredniego oraz pochodna metanosulfonianowa |
DK1628685T3 (da) | 2003-04-25 | 2011-03-21 | Gilead Sciences Inc | Antivirale phosphonatanaloge |
US7511139B2 (en) | 2004-06-04 | 2009-03-31 | Bristol-Myers Squibb Company | Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation |
US20070060599A1 (en) | 2005-09-09 | 2007-03-15 | Dimarco John D | Crystalline forms of [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |
CN101210015B (zh) | 2006-12-26 | 2010-09-22 | 上海国创医药有限公司 | 一种乙肝治疗药物恩替卡韦的制备方法 |
CN101245068A (zh) | 2007-02-14 | 2008-08-20 | 浙江医药股份有限公司新昌制药厂 | 结晶型态的恩替卡韦及其制备方法和其药物组合物及用途 |
CN101245067B (zh) | 2007-02-14 | 2011-09-28 | 浙江金立源药业有限公司 | 一种恩替卡韦的制备方法及其中间体 |
CN101235034A (zh) | 2008-02-28 | 2008-08-06 | 陆锦康 | 恩替卡韦的合成方法 |
-
2008
- 2008-12-26 KR KR1020080134756A patent/KR101150254B1/ko not_active IP Right Cessation
-
2009
- 2009-12-21 AR ARP090105004A patent/AR074821A1/es not_active Application Discontinuation
- 2009-12-23 SA SA109310017A patent/SA109310017B1/ar unknown
- 2009-12-24 EP EP09835300.6A patent/EP2382217B1/en not_active Not-in-force
- 2009-12-24 CN CN200980152328.2A patent/CN102264739B/zh not_active Expired - Fee Related
- 2009-12-24 JP JP2011543432A patent/JP5425933B2/ja not_active Expired - Fee Related
- 2009-12-24 CA CA2747777A patent/CA2747777C/en not_active Expired - Fee Related
- 2009-12-24 US US13/140,640 patent/US8569490B2/en not_active Expired - Fee Related
- 2009-12-24 WO PCT/KR2009/007786 patent/WO2010074534A2/en active Application Filing
- 2009-12-24 SG SG2011040870A patent/SG171963A1/en unknown
- 2009-12-24 MY MYPI2011002833A patent/MY158838A/en unknown
- 2009-12-25 TW TW098145014A patent/TWI383983B/zh not_active IP Right Cessation
-
2012
- 2012-04-16 HK HK12103691.2A patent/HK1163083A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2382217A4 (en) | 2012-08-15 |
US20110251387A1 (en) | 2011-10-13 |
CN102264739A (zh) | 2011-11-30 |
WO2010074534A3 (en) | 2010-11-11 |
JP5425933B2 (ja) | 2014-02-26 |
JP2012513988A (ja) | 2012-06-21 |
SA109310017B1 (ar) | 2013-12-15 |
CN102264739B (zh) | 2014-12-10 |
EP2382217B1 (en) | 2013-10-23 |
SG171963A1 (en) | 2011-07-28 |
TWI383983B (zh) | 2013-02-01 |
CA2747777C (en) | 2013-11-12 |
US8569490B2 (en) | 2013-10-29 |
KR101150254B1 (ko) | 2012-06-12 |
MY158838A (en) | 2016-11-15 |
TW201028417A (en) | 2010-08-01 |
EP2382217A2 (en) | 2011-11-02 |
WO2010074534A2 (en) | 2010-07-01 |
CA2747777A1 (en) | 2010-07-01 |
KR20100076640A (ko) | 2010-07-06 |
HK1163083A1 (en) | 2012-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR074821A1 (es) | Proceso para preparar entecavir e intermediario para dicho proceso | |
BR112018074725A2 (pt) | processo para preparação de n-(5-(3-(7-(3-fluorofenil)-3h-imidazo[4,5-c]piridin-2-il)-1h-indazol-5-il)piridin-3-il)-3-metilbutanamida | |
MX361020B (es) | Procesos para preparar compuestos heterociclicos, incluida trans-7-oxo-6-(sulfooxi)-1,6-diazabiciclo [3,2,1]octano-2-carboxam ida y sales de la misma. | |
PE20171737A1 (es) | Derivados de quinazolinona biciclicos | |
BR112015023036A2 (pt) | método para preparar um produto alcaloide benzilisoquinolina e célula microbiana engenheirada que produz um produto alcaloide benzilisoquinolina | |
NO20071522L (no) | Fremgangsmate for fremstilling av kirale 8-(3-amino-piperidin-1-yl)-xantiner | |
DE602006011482D1 (de) | Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen | |
JOP20160185B1 (ar) | طريقة لتحضير (4s)-4-(4- سيانو-2- ميثوكسي فنيل)-5- إيثوكسي-8،2-داي ميثيل-4،1-داي هيدرو-6،1- نافثيريدين-3- كربوكساميد واسترجاع (4s)-4-(4- سيانو-2- ميثوكسي فنيل)-5- إيثوكسي-8،2- داي ميثيل-4،1- داي هيدرو-6،1- نافثيريدين-3- كربوكساميد بواسطة طرق كهروكيميائية | |
DK2453739T3 (da) | Fremgangsmåde til fremstilling af en vandig suspension af en organisk pesticidforbindelse | |
AR107633A1 (es) | Procedimiento para la preparación del ácido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]-3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxílico | |
GT200600422A (es) | Derivados de carboxamida como antagonistas del receptor muscarinico | |
EA201890547A1 (ru) | Способ получения ингибитора parp, кристаллические формы и их применения | |
GT200500124A (es) | (4-metoxi-7-morfolin-4-il-benzotiazol-2-il) amida del acido 4-hidroxi-4-metil-piperidin-1-carboxilico | |
ATE519832T1 (de) | Verfahren zum erhalt von lipid aus zellen | |
BR112016008354A2 (pt) | processo de preparação de alquilaluminoxanos por meio da reação de alquilalumínio com um álcool alílico substituído da fórmula, produto que pode ser obtido por meio do processo, e, uso do produto | |
AR097710A1 (es) | Fibras de carbono derivadas de poliolefina que contienen boro | |
CY1113184T1 (el) | Μεθοδος για την παρασκευη θεραπευτικως πολυτιμων παραγωγων τριφαινυλβουτενιου | |
MX2016000623A (es) | Proceso para aislar acido levulinico. | |
GT200500317A (es) | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
ES2721623T3 (es) | Procedimiento novedoso para la preparación de ceftarolina fosamil | |
AR085052A1 (es) | Metodos para producir un compuesto profarmaco inhibidor de la union al vih e intermediarios | |
AR054784A1 (es) | Proceso de produccion de potenciadores de blanqueado y compuestos derivados de dihidroinisoquinolina producidos mediante este proceso. | |
CY1118701T1 (el) | Μεθοδος για την ληψη λιπαρων οξεων φαρμακολογικου και θρεπτικου ενδιαφεροντος | |
EA201992709A1 (ru) | Способ получения оптически активного соединения | |
MX2015015717A (es) | Proceso para la separacion de acido formico a partir de metiltetrahidrofurano. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |